JENNIFER ST. JOHN: Open Payments
NPI 1649222027 · PELL CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 24 payments from 8 companies in 2025. Trend: 2023 $384 · 2024 $456 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $144 |
| GlaxoSmithKline, LLC. | 5 | $113 |
| ABBVIE INC. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Abbott Laboratories | 1 | $33 |
| Dexcom, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, Wegovy, VRAYLAR, AIRSUPRA, FREESTYLE LIBRE 3, Ozempic, Dexcom G6 Transmitter, Veozah.
Industry payments across AL — which companies pay providers there.
